Venofer

Phase 2Small molecule

AAzad Pharma AG

Venofer is one of 62 small molecule programs targeting Anemia. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

AnemiaActive, not recruiting

Heart FailureActive, not recruiting

AnemiaPhase 2

Active, not recruiting

Heart FailurePhase 1/Phase 2

Active, not recruiting

Competition

Competitive Landscape

687 competitors in Heart Failure

#DrugCompanyPhaseTrials

Bayer Aspirin

Bayer

Preclinical

2 2

Activase

Zemplar

Xifaxan

2 5

Venofer

AAzad Pharma AG

Phase 2

1 6

Coumadin

AAbbott

Preclinical

1 7

Xylocaine

MMEDRx USA, Inc.

Preclinical

1 8

Oraverse

LLife Extension Foundation Inc.

Preclinical

1 9

Kuvan

BioMarin Pharmaceutical

Preclinical

1 10

Optimal Medical Therapy

HHelios Health Institute GmbH

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 2Recruiting

Anemia

NCT05800600

Clinical

Trials by Indication[1]

Single Dose2 trials

Bioequivalence Study Comparing Single Dose of Ferrinemia® Injection With a Single Dose of Venofer® Injection in Healthy Male Volunteers

Completed·AAzad Pharma AG·Phase 1·NCT03093883·48 enrolled

Bioequivalence Study With Pharmacokinetic Endpoints, Comparing a Single Dose of Iron Sucrose Azad Injection of Azad Pharma Corporation (AG), With a Single Dose of Venofer® Injection of Vifor Corporation (AG) in Healthy Adult Volunteers

Completed·AAzad Pharma AG·Phase 1·NCT02391181·30 enrolled

Anemia2 trials

Comparison of Safety and Efficacy of Intravenous Iron Versus Oral Iron in Chronic Renal Failure Subjects With Anemia

Completed·AAmerican Regent, Inc.·Phase 3·NCT00236977·182 enrolled

Iron Replacement to Reduce Anemia During Neoadjuvant Chemotherapy

Recruiting·FFox Chase Cancer Center·Phase 2·NCT05800600·34 enrolled

Bariatric Surgery1 trial

The Use of Liposomated Iron After Bariatric Surgery in Patients That Are Receiving Parentheral Therapy With Iron

Completed·HHospital Universitari Vall d'Hebron Research Institute·Phase 4·NCT02390921·40 enrolled

Pediatric Patients1 trial

Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients

Completed·AAmerican Regent, Inc.·Phase 2·NCT00721188·11 enrolled

Adult Subject1 trial

Bioequivalence Study Assessing Iron Sucrose or Venofer® in Healthy Adult Subjects

Completed·BBaxter Healthcare Corporation·Phase 1·NCT04155814·196 enrolled

4 more indications

Hemodialysis1 trial

Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients

Completed·AAmerican Regent, Inc.·Phase 4·NCT06690450·400 enrolled

Safety and Efficacy1 trial

Safety and Efficacy of Iron Sucrose in Children

Completed·AAmerican Regent, Inc.·Phase 4·NCT00239642·141 enrolled

Pregnancy1 trial

Intravenous Versus Oral Iron in Late Pregnancy: Results of Treatment

Completed·MMahidol University·Phase 4·NCT00746551·80 enrolled

Heart Failure1 trial

Effect of Intravenous Ferrous Sucrose on Exercise Capacity in Chronic Heart Failure

Unknown status·NNational Heart and Lung Institute·Phase 1/2·NCT00125996·42 enrolled

Sources

References

[1]
ClinicalTrials.gov — 11 trial records for Venofer. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Venofer compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Venofer. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Azad Pharma AG company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: AAzad Pharma AG

Venofer

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Single Dose2 trials

Anemia2 trials

Bariatric Surgery1 trial

Pediatric Patients1 trial

Adult Subject1 trial

Hemodialysis1 trial

Safety and Efficacy1 trial

Pregnancy1 trial

Heart Failure1 trial

References

Drug Info

Quick Facts

Related News